TELEBRIX 30 MEGLUMINE,100ML

Riik: Malaisia

keel: inglise

Allikas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Osta kohe

Toote omadused Toote omadused (SPC)
12-03-2018

Toimeaine:

Meglumine Ioxitalamate

Saadav alates:

MEDI-DIAGNOSTIC SOLUTIONS (M) SDN. BHD.

INN (Rahvusvaheline Nimetus):

Meglumine Ioxitalamate

Ühikuid pakis:

50ml mL; 100ml mL; 30ml mL

Valmistatud:

LABORATOIRE GUERBET

Toote omadused

                                TELEBRIX	® 30 MEGLUMINE (300mg I/ml)	Solution for injection COMPOSITION Meglumine ioxitalamate……………………………………………………………..........66.0300g Sodium calcium edetate….............................................................0.0086g Sodium dihydrogen phosphate, dihydrate....................................... 0.0500g Water for injection....................................................................q.s. 100ml Osmolality: 1710mOsm/kg Iodine content: 30%, or 300mg per ml Solution for injection in bottles of 30ml, 50ml, 100ml, 200ml. Metabolic fate After intravascular injection, water-soluble tri-iodinated compounds are distributed throughout the vascular space and the interstitial space. Elimination is mainly renal (glomerular filtration). In the case of renal failure, a heterotopic elimination occurs primarily via the biliary tract and to a lesser extent via the saliva, sweat and colon. Indication Specific indications: -cerebral arteriography due to poor tolerance by the cerebral tissue, of sodium salt and iodine-concentrated solutions; -selective arteriography; -phlebography; General indications: Those of water soluble, triiodo contrast agents (intravenous urography in infants and children, computed tomography, etc.). Contraindication Telebrix	® 30 Meglumine is definitely contraindicated for myelography. Warning Water-soluble, tri-iodinated contrast media can give rise to adverse reactions including sometimes severe, even occasionally fatal, reactions. These reactions are more frequent in patients with a history of untoward reactions to prior examinations with intravascular radio diagnostic compounds or in those presenting a positive history of allergy (asthma, eczema, urticaria, hay fever, miscellaneous food or drug allergic…), but they always occur without warning. They cannot be predicted using iodine sensitivity tests which are useless and is some instances can even be dangerous. Throughout the procedure, continuous medical supervision (particularly of the pu
                                
                                Lugege kogu dokumenti
                                
                            

Otsige selle tootega seotud teateid